Navigation Links
Mission Pharmacal Launches New Vitamin B6-Rich Prescription Prenatal Vitamin, CitraNatal(R) B-Calm
Date:3/1/2010

SAN ANTONIO, March 1 /PRNewswire/ -- Mission Pharmacal announced today the addition of CitraNatal® B-Calm to its CitraNatal® family of prescription prenatal vitamins.  CitraNatal B-Calm offers gentle prenatal nutrition plus the benefits of additional vitamin B6, which supplements a woman's own defense against severe pregnancy-related nausea and vomiting.  Emerging science suggests that vitamin B6 supplementation can be beneficial for pregnant women who suffer with severe nausea during pregnancy.

"For many women, pregnancy-related nausea and vomiting can be a serious concern," said Neill Walsdorf, Jr., president of Mission Pharmacal.  "We are pleased to offer women a prenatal vitamin option that may help provide some relief during their pregnancies, while providing the quality and comfort women have come to trust with the CitraNatal name."

As many as 85 percent of pregnant women may experience nausea and up to half may experience vomiting early during their pregnancies.  With 75 mg of vitamin B6 dosed over 24 hours, CitraNatal B-Calm may be used in conjunction with a physician prescribed regimen to help minimize these symptoms.

CitraNatal B-Calm contains 25 mg of vitamin B6 in the multivitamin and two 25 mg vitamin B6 supplements to be taken at eight-hour intervals.  Vitamin B6 is recommended by The American College of Obstetricians and Gynecologists as a safe and effective first-line supplementation for pregnancy-related nausea and vomiting.  The multivitamin tablet also contains a signature CitraNatal formula with gentle ingredients for mom and strong nutrition for baby, including folic acid, calcium citrate and carbonyl iron.

In addition, Mission Pharmacal is currently working to add a recently acquired, dual-iron technology into the existing CitraNatal family of prescription prenatal vitamins, including CitraNatal B-Calm, as well as Ferralet 90, a prescription oral iron supplement for the treatment of iron deficiency anemia.  The new technology is a varied release of carbonyl iron and ferrous gluconate that combines the quick uptake of a ferrous salt and the more prolonged absorption in the body of carbonyl iron.

Women who are pregnant or planning to conceive should consult their healthcare providers prior to beginning any prenatal vitamin regimen.

About the CitraNatal® Line

CitraNatal is marketed by Mission Pharmacal Company based in San Antonio, Texas.  CitraNatal vitamins are specially formulated for the many women who require nutritional support prior to conception, throughout pregnancy, and during the postnatal period.  The plant-derived DHA found in several CitraNatal products is produced exclusively by Martek Biosciences Corporation based in Columbia, Maryland.

About Mission Pharmacal

Mission Pharmacal is a privately held pharmaceutical company based in San Antonio, Texas.  For more than 60 years, the company has been committed to meeting the unique needs of women throughout all stages of life, identifying unmet health needs in the marketplace, and developing innovative prescription and over-the-counter products to meet them.  Currently, Mission Pharmacal provides physicians and consumers with pharmaceutical and nutritional products.  For more information, visit www.missionpharmacal.com or www.citranatal.com.

SOURCE Mission Pharmacal

Back to top

RELATED LINKS
http://www.missionpharmacal.com

'/>"/>

SOURCE Mission Pharmacal
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Indevus Announces Submission of New Drug Application
2. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
3. BD Announces FDA 510(K) Submission of Rapid Molecular Test to Identify Patients Carrying Staph Superbug Prior to Surgery
4. Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies
5. Game Commission Announces EHD Confirmed in Fayette County
6. Test for Life Commends North Carolina Rules Commission for Implementing CDC Recommendations for HIV Testing
7. PARIs eFlow Included in Gileads NDA Submission for Aztreonam Lysine for Inhalation
8. Wyeths TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer
9. Genasense Plus Chemotherapy Is Associated With Prolonged Survival in Patients With Relapsed/Refractory CLL Who Achieve Complete Remission
10. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
11. FDA to Extend Review of Data Quality Submission for Genasense(R) in Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The Global Endoscopy Market is poised to grow ... reach approximately $47.6 billion by 2025. This industry ... segments on global as well as regional levels presented in the ...
(Date:2/23/2017)... Ga., Feb. 23, 2017  MiMedx Group, Inc. (NASDAQ: ... tissue and patent-protected processes to develop and market advanced ... Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, ... and full year ended December 31, 2016. ... Revenue is a 31% increase over full year 2015 ...
(Date:2/23/2017)... Feb. 23, 2017   SeraCare Life Sciences ... in vitro diagnostics manufacturers and clinical laboratories, is ... Implementation of NGS-Based Tests" to be hosted by ... at 11am Eastern Standard Time (US). ... the need for improved performance and global standardization ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... February 23, 2017 , ... Rare Disease ... will be participating in Rare Disease Day events, hosted by the Rare Disease ... Disease Report, a website, weekly e-newsletter and quarterly publication, will be conducting interviews ...
(Date:2/23/2017)... ... 23, 2017 , ... Los Angeles-based weight loss surgeon Michael Feiz, M.D., F.AC.S. ... Not to Hot,” which will begin airing on February 24, 2017. The show chronicles ... the 2012 reality television series, “Here Comes Honey Boo Boo.” The earlier series from ...
(Date:2/23/2017)... NJ (PRWEB) , ... February 23, 2017 , ... ... in thought leadership , media relations, content marketing, social media management, corporate ... several clients already in the state and in nearby New Hampshire, Massachusetts and ...
(Date:2/23/2017)... Angeles, California (PRWEB) , ... February 23, 2017 ... ... Global Sports Development will host a diverse symposium on “Doping in ... of Law and Sheppard Mullin Richter & Hampton LLP. The symposium will be ...
(Date:2/23/2017)... ... 2017 , ... Pink Pig Publishing LLC announces the launch ... the world from different perspectives. By providing a place for people of all ... empathy, and find greater happiness. , "Our approach to structuring content is ...
Breaking Medicine News(10 mins):